In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Isolagen nets $57mm with FOPO

Executive Summary

Isolagen (autologous cellular system--ACS--technology for soft and hard tissue regeneration) has netted about $57mm (including the overallotment; 850k of the 1050k overallotment shares were offered by the selling shareholders) with a 7.2mm common-share follow-on public offering priced at $8.50 per share.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies